Prime editing reaches a patient with Wilson disease

Where it stands as of Oct 25, 2026

Prime Medicine has dosed the first person with an intravenous prime-editing infusion for Wilson disease, the first known use of the technique inside a human body. First results are due in 2027. No outcome number has been reported yet, so whether it works and is safe in people is not known.